Login / Signup

Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.

Giuliano CostaThomas PilgrimIgnacio J Amat SantosOle de BackerWon Keun KimHenrique Barbosa RibeiroFrancesco SaiaMatjaz BuncDidier TchetchePhilippe GarotFlavio Luciano RibichiniDzxcfewarren MylotteFrancesco BurzottaYusuke WatanabeFrederico DeMarcoTullio TesorioTobias RheudeMarco TocciAnna FranzoneRoberto ValvoMikko SavontausHendrik WienemannItalo PortoCaterina GandolfoAlessandro IadanzaAlessandro Santo BortoneMarkus MachAzeem LatibLuigi BiascoMaurizio TaramassoMarco ZimarinoDaijiro TomiiPhilippe NuyensLars SondergaardSergio F CamaraTullio PalmeriniMatheusz OrzalkiewiczKlemen SteblovnikBastien DegrelleAlexandre GautierPaolo Alberto Del SoleAndrea MainardiMichele PighiMattia LunardiHideyuki KawashimaEnrico CriscioneVincenzo CesarioFausto BiancariFederico ZaninMichael JonerGiovanni EspositoMatti AdamEberhard GrubeStephan BaldusVincenzo De MarzoElisa PireddaStefano CannataFortunato IacovelliMartin AndreasValentina FrittittaElena DipietroClaudia ReddavidOrazio StrazzieriSilvia MottaDomenico AngellottiCarmelo SgroiFaraj KargoliCorrado TamburinoMarco Barbantinull null
Published in: Circulation. Cardiovascular interventions (2022)
The present analysis of the REVASC-TAVI registry showed that, among TAVI patients with significant stable CAD found during the TAVI work-up, completeness of myocardial revascularization achieved either staged or concomitantly with TAVI was similar to a strategy of incomplete revascularization in reducing the risk of all cause death, as well as the risk of death, stroke, myocardial infarction, and rehospitalization for heart failure at 2 years, regardless of the clinical and anatomical situations.
Keyphrases